Immuneering Corporation Class A (IMRX) Dividend History

Immuneering Corporation Class A (IMRX) is a biotechnology company focused on developing therapies for complex neurological and oncology diseases. Founded with the goal of translating computational biology and data-driven insights into innovative treatments, Immuneering leverages its proprietary platform to identify and advance novel drug candidates. The company aims to accelerate drug discovery and improve patient outcomes through its expertise in genomics, computational models, and clinical development.

245 Main Street, Second Floor, Cambridge, MA, 02142
Phone: 617-500-8080
Website: https://www.immuneering.com

Dividend History

Immuneering Corporation Class A currently does not pay dividends

Company News

  • Immuneering reported positive data from its ongoing Phase 2a trial of atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-Paclitaxel (mGnP) for first-line pancreatic cancer patients, including 94% overall survival at 6 months and a favorable tolerability profile.

    GlobeNewswire Inc.
  • Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates. SAIC reported a 12% revenue decline Y/Y in the fourth quarter of fiscal 2024 to $1.74 billion, beating the consensus of $1.64 billion. Adjusted EPS of $1.43 was in line with the consensus. Science Applications International shares dipped 10.7% to $127.29 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Canoo Inc. (NASDAQ: GOEV) shares surged 95% to $3.77 after the US Department of Commerce has approved its Oklahoma City facility as a Foreign Trade Zone. Solidion Technology Inc. (NASDAQ: STI) shares jumped 71.9% to $2.9910 after surging around 34% on Friday. The company, last week, announced the pricing of a $3.85 million private placement. Verb Technology Company, Inc. (NASDAQ: VERB) gained 53% to $0.6770, possibly on continued strength after it announced its Market.live launched Facebook and Instagram social shopping technology integration on Friday. WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 39.1% to $4.1461. WaveDancer and Firefly Neuroscience each received the requisite stockholder approvals required to consummate the merger between both companies. Brand Engagement Network, Inc. (NASDAQ: BNAI) climbed 33.7% to $14.14 after jumping 40% on Friday. Wearable Devices Ltd. (NASDAQ: WLDS) climbed 31.6% to $0.5863. Wearable Devices published a report by its XR team suggesting 'The Mudra Band Can Be The Neural Bridge For Apple And Meta In Their Next Wave Of Smart Glasses Interaction.' Leafly Holdings, Inc. (NASDAQ: LFLY) rose 30.3% to $2.86. Immuneering Corporation (NASDAQ: IMRX) surged 30.3% to $2.49. Immuneering recently announced topline result from the ongoing Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors. Nuvei Corp (NASDAQ: NVEI) rose 25.8% to $27.24 after the company said it was evaluating offers to go private. Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) surged 25.4% ...

    Benzinga
  • Immuneering (IMRX) plunges after multiple Wall Street analysts downgraded the stock on lackluster results from an early-stage study evaluating its lead drug across advanced RAS-mutant solid tumors.

    Zacks Investment Research
    Featured Companies: ADMA ANIP
  • Immuneering is ready to share information regarding its lead therapy.

    The Motley Fool
  • Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

    Seeking Alpha
Page data last updated 07/23/2025 17:24:45 UTC